MaxiVAX
Series BMaxiVAX raised €4.6M in a Series B round in Oct 2019. The company is based in Geneva, Switzerland. Data as of Nov 2026.
Amount raised
€4.6M
€4,609,569
Native amount
5,000,000 CHF
Stage
Series B
series b
Investors
0
Provenance & confidence
High confidenceAmount
5,000,000 CHF
ECB-at-date → €4.6M · rate 1.0847 on 2019-09-30
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
0 namedNo investors disclosed for this round.
Date
Oct 2019
Round type
series b
Amount (EUR)
€4.6M
Other rounds
same companyThis is the company's only recorded round.